Consistent with these results, depletion of PFKP inhibited the growth of brain tumors derived from intracranially injected U87/EGFRvIII cells (Fig. 1g) and reduced tumor cell proliferation, as evidenced by the intensity of Ki-67 expression (Fig. 1h). Here, PFKP is linked to neoplasm.